Ortivus AB (publ) quarterly report for the period January – March 2021

Ortivus is growing and attracting additional distributors. Operating cash flow improved to 5.1 MSEK during the first quarter 2021.

Highlights Jan – Mar 2021

  • Ortivus has signed a distribution agreement with Bexen Cardio Italia Srl to create new marketing and sales channels in Italy.

Jan – Mar 2021

  • Net sales amounted to 23.5 (20.2) MSEK, which is an increase in sales of 17%
  • Operating cash flow amounted to 5.1 (3.2) MSEK
  • Operating profit amounted to 1.7 (1.1) MSEK
  • Profit after tax was 1.7 (1.1) MSEK
  • Earnings per share after tax and before and after dilution amounted to 0.04 (0.02) SEK
Amount in KSEK Jan-Mar 2021 Jan-Mar 2020 Jan-Dec 2020
Net sales 23 542 20 161 107 582
Gross margin, % 50.1% 44.4% 36.2%
Operating cash flow 5 104 3 166 11 895
Operating profit 1 733 1 112 11 392
Operating margin, % 7.4% 5.5% 10.5%
This entry was posted in . Bookmark the permalink.